Return to homepagePandemic Pact

Development of novel complement targeting antibody therapy against fatal COVID-19 complications.

  • Funded by Japan Agency for Medical Research and Development (AMED)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2020

  • Funder

    Japan Agency for Medical Research and Development (AMED)

  • Principal Investigator

    Pending

  • Research Location

    Japan

  • Lead Research Institution

    T-CiRA Discovery, Takeda pharmaceutical company limited.

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract